RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
215 hedge funds and large institutions have $2.07B invested in Revance Therapeutics, Inc. in 2023 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 86 increasing their positions, 60 reducing their positions, and 39 closing their positions.
Holders
215
Holders Change
-1
Holders Change %
-0.46%
% of All Funds
3.39%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
39
Increased
86
Reduced
60
Closed
39
Calls
$36.5M
Puts
$20.2M
Net Calls
+$16.2M
Net Calls Change
-$18.3M